MK-677 vs CJC-1295: Which Should You Use for Growth?
MK-677 and CJC-1295 both raise growth hormone but through different receptors, and many people use them together rather than choosing one.
Quick Answer
MK-677 is for people who want a pill that raises growth hormone without daily injections. CJC-1295 is for people who prefer an injectable that more closely mimics the body's own natural growth hormone signal. The verdict: these two are often better together than as alternatives to each other.
What Is MK-677?
MK-677 (also called ibutamoren) is taken by mouth. This sets it apart from almost every other compound in the growth hormone space.
It copies the hunger hormone ghrelin (GREE-lin). This signal tells the pituitary gland (a small gland at the base of the brain) to release more growth hormone (GH). It also raises a downstream signal called insulin-like growth factor 1 (IGF-1), which plays a role in muscle and recovery.
Typical doses used in research range from 10 mg to 25 mg per day (source). MK-677 has a long half-life and stays active throughout the day .
Common side effects include increased appetite, water retention, and, in some people, elevated blood sugar . Because it stimulates hunger through the ghrelin system, expect to feel noticeably hungrier, especially at the start.
What Is CJC-1295?
CJC-1295 is an injectable peptide that copies growth hormone releasing hormone (GHRH). GHRH is the signal your body uses to start a pulse of GH release from the pituitary.
It comes in two forms. CJC-1295 without DAC (drug affinity complex) has a short window of activity and needs to be injected more frequently. CJC-1295 with DAC attaches to a blood protein and stays active for up to 1 to 2 weeks per injection .
Typical research doses range from 1 mcg per kilogram of body weight to 2 mcg per kilogram per injection . GH release happens in a pulse, which is closer to how the body naturally produces it.
How Do MK-677 and CJC-1295 Work Differently?
The core difference is the receptor each one targets.
MK-677 acts on the ghrelin receptor. CJC-1295 acts on the GHRH receptor. These are two completely different receptor systems. Both trigger the pituitary to release GH, but they do it through separate switches.
Mechanism: MK-677 copies ghrelin. CJC-1295 copies GHRH. Different receptors, same end result.
Route: MK-677 is oral. CJC-1295 is injected under the skin.
Primary use: Both are studied for their effects on growth hormone, body composition, and recovery.
Typical research dose:
- MK-677: 10 mg to 25 mg per day, by mouth
- CJC-1295 without DAC: 1 to 2 mcg/kg per injection, multiple times per week
- CJC-1295 with DAC: 1 to 2 mcg/kg per injection, once every 1 to 2 weeks
Onset: MK-677 raises GH and IGF-1 within hours and sustains it throughout the day . CJC-1295 without DAC triggers a GH pulse within 30 to 60 minutes of injection that fades over hours . With DAC, GH levels stay elevated for a longer window .
Evidence level: Both have limited human clinical data (source). Most of the research comes from small trials or animal studies. Honest flag: these compounds are not FDA-approved for general use, and long-term human safety data is thin.
Tracking your growth hormone protocol, including dose timing, IGF-1 test results, and how you feel week over week, is much easier with a dedicated log. DoseVault is built exactly for that kind of structured tracking.
How Do MK-677 and CJC-1295 Compare Side by Side?
| Feature | MK-677 | CJC-1295 |
|---|---|---|
| How you take it | By mouth (pill or liquid) | Injected under the skin |
| Receptor targeted | Ghrelin receptor | GHRH receptor |
| Half-life | Long, active all day | Short (no DAC) or up to 2 weeks (with DAC) |
| Typical research dose | 10 to 25 mg per day | 1 to 2 mcg/kg per injection |
| Appetite effect | Significant increase | Minimal |
| IGF-1 increase | Yes | Yes |
| Human clinical data | Limited | Limited |
Can You Stack MK-677 and CJC-1295?
Yes, and this is one of the most common combinations in the research peptide space.
Because they act on different receptors, MK-677 and CJC-1295 can work together without competing. MK-677 hits the ghrelin receptor and CJC-1295 hits the GHRH receptor. Both push the pituitary toward more GH output through separate channels .
That said, long-term human data on stacking these two is limited . Anyone combining them should understand this is not a studied combination in the way that pharmaceutical drugs are tested.
Which One Do People Pick, and When?
People pick MK-677 when they want growth hormone support without daily injections and do not mind the hunger side effect. The oral route makes it easy to stay consistent.
People pick CJC-1295 when they want a more physiological GH pulse and are comfortable with injections. Many people use the with-DAC version for convenience.
People who use both often do it to hit the ghrelin and GHRH pathways at the same time. This is general guidance, not personalized medical advice.
Related
- MK-677
- CJC-1295
- Bacteriostatic Water vs Sterile Water for Peptides
- Can Peptides Be Taken Orally or Do They Need Injection?
- Can You Mix Two Peptides in One Syringe?
- Peptides for Muscle and Strength
- CJC-1295 Dosage
Disclaimer
This page is for educational purposes only. It is not medical advice. Nothing here should be used to diagnose, treat, cure, or prevent any condition. MK-677 and CJC-1295 are not FDA-approved for general use. Consult a qualified healthcare provider before using any compound.
Built by medical professionals, gym rats, and experienced biohackers
Log your MK-677 or CJC-1295 protocol, track IGF-1 results, and monitor how your body responds over time with DoseVault.